Clinical Trial

A Multi-center, Prospective, Registry Study to Analyze the Clinical Characteristics and Prognosis of Different Molecular Subtypes of Peripheral T-cell Lymphoma.

Name: A Multi-center, Prospective, Registry Study to Analyze the Clinical Characteristics and Prognosis of Different Molecular Subtypes of Peripheral T-cell Lymphoma. — clinical trial record (NCT07657572)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: EXCELLENT

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

A multi-center, prospective, registry study to analyze the clinical characteristics and prognosis of different molecular subtypes of peripheral T-cell lymphoma.

Trial Details

NCT Number	NCT07657572
Lead Sponsor	Ruijin Hospital
Conditions	PTCL, T Cell Lymphoma
Enrollment	1,000 participants
Start Date	2026-06
Primary Completion	2029-12 (estimated)
Study Completion	2030-12 (estimated)
Updated on ClinicalTrials.gov	2026-06-18